Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021

Thrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran Kiem, Cécile, Andronico, Alessio, Bosetti, Paolo, Paireau, Juliette, Alter, Lise, Boëlle, Pierre-Yves, Fontanet, Arnaud, Lévy-Bruhl, Daniel, Cauchemez, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326661/
https://www.ncbi.nlm.nih.gov/pubmed/34212840
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326661/
https://www.ncbi.nlm.nih.gov/pubmed/34212840
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100533

Ejemplares similares